Drug · DIN 02502895
ANTHIM
SINGLE-USE VIAL
Restricted access only
Authorized for restricted access only.
Status Restricted Access since September 13, 2022.
- Drug Identification Number (DIN)
- 02502895
- Company (DIN owner)
- Elusys Therapeutics IncBoca Raton, Florida, United States
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Obiltoxaximab J06BC04
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OBILTOXAXIMAB | 100 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 30, 2020: NOC 23982New Drug Submission (NDS)